Beta-blockers linked to lower mortality in high-risk prostate cancer
Posted on: 10/02/2014 - 22:25
The use of beta-blockers in men with metastatic and high-risk prostate cancer was associated with a reduced risk of prostate cancer–specific mortality independent of statin or acetylsalicylic acid...
Field of Interest: Oncology
Type: News Item